Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes
ACS Catalysis · 21.04.2023 · 13 (8) · 5752-5758
DOI: 10.1021/acscatal.3c01219 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Catalysis, online erschienen am 13.04.2023. Verfasst von Liangliang Yang und 7 weiteren Autor:innen. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., He, J., Wang, H., Xu, W., Zhang, X., Lang, M., Wang, J., & Peng, S. (2023). Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes. ACS Catalysis, 13(8), 5752-5758. https://doi.org/10.1021/acscatal.3c01219
Vancouver
Yang L, He J, Wang H, Xu W, Zhang X, Lang M, et al. Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes. ACS Catalysis. 2023;13(8):5752-5758. doi:10.1021/acscatal.3c01219
BibTeX
@article{Yang2023,
author = {Yang, Liangliang and He, Jieyin and Wang, Haiyang and Xu, Wendi and Zhang, Xue and Lang, Ming and Wang, Jian and Peng, Shiyong},
title = {Asymmetric (5 + 3) Annulation of Donor–Acceptor Cyclopropanes with Imidazolidines: Access to Saturated 1,4-Diazocanes},
journal = {ACS Catalysis},
year = {2023},
volume = {13},
number = {8},
pages = {5752--5758},
doi = {10.1021/acscatal.3c01219}
}
EUVIMED